Cargando…
In silico identification and experimental validation of cellular uptake by a new cell penetrating peptide P1 derived from MARCKS
Viral vectors for vaccine delivery are challenged by recently reported safety issues like immunogenicity and risk for cancer development, and thus there is a growing need for the development of non-viral vectors. Cell penetrating peptides (CPPs) are non-viral vectors that can enter plasma membranes...
Autores principales: | Chen, Linlin, Guo, Xiangli, Wang, Lidan, Geng, Jingping, Wu, Jiao, Hu, Bin, Wang, Tao, Li, Jason, Liu, Changbai, Wang, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330795/ https://www.ncbi.nlm.nih.gov/pubmed/34338123 http://dx.doi.org/10.1080/10717544.2021.1960922 |
Ejemplares similares
-
In silico identification and experimental validation of cellular uptake and intracellular labeling by a new cell penetrating peptide derived from CDN1
por: Guo, Xiangli, et al.
Publicado: (2021) -
Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L
por: Geng, Jingping, et al.
Publicado: (2020) -
MARCKS and MARCKS-like proteins in development and regeneration
por: El Amri, Mohamed, et al.
Publicado: (2018) -
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
por: Madani, Fatemeh, et al.
Publicado: (2011) -
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
por: Eustace, Nicholas J., et al.
Publicado: (2020)